Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor β-activated kinase 1 (TAK1) in interleukin-1β-induced cell signaling

Molecular Immunology

Volumn 46, Issue 4, 2009, Pages 541-550

  Shi, Lijun ^a   Zhang, Zhengping ^a   Fang, Shuping ^a   Xu, Junfeng ^a   Liu, Junhong ^a   Shen, Jiayin ^a   Fang, Fang ^a   Luo, Lan ^b   Yin, Zhimin ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Geldanamycin; Hsp90; IL 1 ; Inflammation; TAK1

Indexed keywords

CYCLOOXYGENASE 2; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; UBIQUITINATION;

BENZOQUINONES; CELL LINE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; ENZYME INHIBITORS; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LACTAMS, MACROCYCLIC; MAP KINASE KINASE KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 58249118857     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.07.019     Document Type: Article

References (58)

1. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R., Davis R.J., and Ronai Z. Regulation of JNK signaling by GSTp. EMBO J. 18 (1999) 1321-1334
2. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
3. Alford K.A., Glennie S., Turrell B.R., Rawlinson L., Saklatvala J., and Dean J.L. Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling. J. Biol. Chem. 282 (2007) 6232-6241
4. Basso A.D., Solit D.B., Chiosis G., Giri B., Tsichlis P., and Rosen N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277 (2002) 39858-39866
5. Baud V., Liu Z.G., Bennett B., Suzuki N., Xia Y., and Karin M. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13 (1999) 1297-1308
6. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli S., Hopf C., Huhse B., Mangano R., Michon A.M., Schirle M., Schlegl J., Schwab M., Stein M.A., Bauer A., Casari G., Drewes G., Gavin A.C., Jackson D.B., Joberty G., Neubauer G., Rick J., Kuster B., and Superti-Furga G. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat. Cell Biol. 6 (2004) 97-105
7. Bowie A., and O'Neill L.A. The interleukin-1receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67 (2000) 508-514
8. Broemer M., Krappmann D., and Scheidereit C. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation. Oncogene 23 (2004) 5378-5386
9. Bucci M., Roviezzo F., Cicala C., Sessa W.C., and Cirino G. Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br. J. Pharmacol. 131 (2000) 13-16
10. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., Lewis A., Ray K., Tschopp J., and Volpe F. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2 (2000) 346-351
11. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., and Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273 (1998) 12203-12209
12. Chen G., Cao P., and Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 9 (2002) 401-410
13. Chen H., Wu Y., Zhang Y., Jin L., Luo L., Xue B., Lu C., Zhang X., and Yin Z. Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett. 580 (2006) 3145-3152
14. Citri A., Harari D., Shohat G., Ramakrishnan P., Gan J., Lavi S., Eisenstein M., Kimchi A., Wallach D., Pietrokovski S., and Yarden Y. Hsp90 recognizes a common surface on client kinases. J. Biol. Chem. 281 (2006) 14361-14369
15. Dayer J.M., and Bresnihan B. Targeting interleukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum. 46 (2002) 574-578
16. De Nardo D., Masendycz P., Ho S., Cross M., Fleetwood A.J., Reynolds E.C., Hamilton J.A., and Scholz G.M. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors. J. Biol. Chem. 280 (2005) 9813-9822
17. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
18. Dinarello C.A., and Wolff S.M. The role of interleukin-1 in disease. N. Engl. J. Med. 328 (1993) 106-113
19. Fan Y., Wu D., Jin L., and Yin Z. Human glutamylcysteine synthetase protects HEK293 cells against UV-induced cell death through inhibition of c-Jun NH2-terminal kinase. Cell Biol. Int. 29 (2005) 695-702
20. Farrar M.A., Alberol I., and Perlmutter R.M. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 383 (1996) 178-181
21. Fink A.L. Chaperone-mediated protein folding. Physiol. Rev. 79 (1999) 425-449
22. Huang J., Gao X., Li S., and Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12829-12832
23. Ishitani T., Takaesu G., Ninomiya-Tsuji J., Shibuya H., Gaynor R.B., and Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22 (2003) 6277-6288
24. Kaur S., Wang F., Venkatraman M., and Arsura M. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J. Biol. Chem. 280 (2005) 38599-38608
25. Matsumoto S., Tanaka E., Nemoto T.K., Ono T., Takagi T., Imai J., Kimura Y., Yahara I., Kobayakawa T., Ayuse T., Oi K., and Mizuno A. Interaction between the N-terminal and middle regions is essential for the in vivo function of HSP90 molecular chaperone. J. Biol. Chem. 277 (2002) 34959-34966
26. Morimoto R.I., Kline M.P., Bimston D.N., and Cotto J.J. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 32 (1997) 17-29
27. Neckers L., and Ivy S.P. Heat shock protein 90. Curr. Opin. Oncol. 15 (2003) 419-424
28. Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., and Yokoyama K. Mechanism of dimer formation of the 90-kDa heat-shock protein. Eur. J. Biochem. 233 (1995) 1-8
29. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 (1999) 252-256
30. Ogimoto K., Harris Jr. M.K., and Wisse B.E. MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta. Endocrinology 147 (2006) 4445-4453
31. Pearl L.H., and Prodromou C. Structure and in vivo function of Hsp90. Curr. Opin. Struct. Biol. 10 (2000) 46-51
32. Picard D., Khursheed B., Garabedian M.J., Fortin M.G., Lindquist S., and Yamamoto K.R. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348 (1990) 166-168
33. Pratt W.B., and Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18 (1997) 306-360
34. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42 (1999) 260-266
35. Sato S., Fujita N., and Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10832-10837
36. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
37. Scheibel T., Siegmund H.I., Jaenicke R., Ganz P., Lilie H., and Buchner J. The charged region of Hsp90 modulates the function of the N-terminal domain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1297-1302
38. Scheibel T., Weikl T., and Buchner J. Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1495-1499
39. Schulte T.W., Akinaga S., Soga S., Sullivan W., Stensgard B., Toft D., and Neckers L.M. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones 3 (1998) 100-108
40. Schulte T.W., An W.G., and Neckers L.M. Geldanamycin-induced destabilization of Raf-1 involves the proteasome. Biochem. Biophys. Res. Commun. 239 (1997) 655-659
41. Sharp S., and Workman P. Inhibitors of the HSP90 molecular chaperone: current status. Adv. Cancer Res. 95 (2006) 323-348
42. Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., and Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272 (1996) 1179-1182
43. Singer C.A., Baker K.J., McCaffrey A., AuCoin D.P., Dechert M.A., and Gerthoffer W.T. p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L1087-L1098
44. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2 (2002) 185-194
45. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., and Pavletich N.P. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89 (1997) 239-250
46. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., Ninomiya-Tsuji J., and Matsumoto K. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5 (2000) 649-658
47. Takaesu G., Surabhi R.M., Park K.J., Ninomiya-Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326 (2003) 105-115
48. Teng S.C., Chen Y.Y., Su Y.N., Chou P.C., Chiang Y.C., Tseng S.F., and Wu K.J. Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. J. Biol. Chem. 279 (2004) 14649-14655
49. Tsuda M., Langmann C., Harden N., and Aigaki T. The RING-finger scaffold protein plenty of SH3s targets TAK1 to control immunity signalling in Drosophila. EMBO Rep. 6 (2005) 1082-1087
50. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
51. Welch W.J., and Feramisco J.R. Purification of the major mammalian heat shock proteins. J. Biol. Chem. 257 (1982) 14949-14959
52. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., and Neckers L.M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8324-8328
53. Xu Y., and Lindquist S. Heat-shock protein hsp90 governs the activity of pp60v-src kinase. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7074-7078
54. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., and Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270 (1995) 2008-2011
55. Yang K., Shi H., Qi R., Sun S., Tang Y., Zhang B., and Wang C. Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells. Mol. Biol. Cell 17 (2006) 1461-1471
56. Yao J., Kim T.W., Qin J., Jiang Z., Qian Y., Xiao H., Lu Y., Qian W., Gulen M.F., Sizemore N., DiDonato J., Sato S., Akira S., Su B., and Li X. Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J. Biol. Chem. 282 (2007) 6075-6089
57. Young J.C., Moarefi I., and Hartl F.U. Hsp90: a specialized but essential protein-folding tool. J. Cell Biol. 154 (2001) 267-273
58. Zhang R., Luo D., Miao R., Bai L., Ge Q., Sessa W.C., and Min W. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. Oncogene 24 (2005) 3954-3963